Oregon Prescription Drug Affordability Board, March 18, 2026
Oregon Prescription Drug Affordability Board · March 18, 2026
The Oregon Prescription Drug Affordability Board met on 2026-03-18, approved the final 2025 drug review report with two policy concepts (a targeted out‑of‑pocket cap and a point‑of‑sale rebate pass‑through) to send to the legislature, and selected a 2026 subset of drugs (including two orphan drugs) plus two insulin products for carrier data calls.
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.
No transcript available.
No outline available for this source.
No related articles available for this source.
No highlights available for this source.
No claims available for this source.
No actions available for this source.
No topics available for this source.
No clarifying details available for this source.
No discussions available for this source.
No community relevance data available for this source.
No funding sources available for this source.
No speakers available for this source.
No transcript available for this source.